Search

These souped-up versions may help overcome some limitations of existing CAR T cells.

… Thursday, December 30, 2021 Immunotherapies called chimeric antigen receptor (CAR) T cells use genetically engineered versions of a patient’s own immune cells to fight cancer. These treatments have energized cancer care, especially for people with certain types of blood cancers. Now, scientists at Memorial

Researchers led by scientists at Memorial Sloan Kettering Cancer Center have now identified fundamentally novel regulatory mechanisms of PTEN function. The findings from two related studies are published in the January 12 issue of Cell.

… Friday, January 12, 2007 PTEN is one of the most commonly mutated tumor suppressor genes. It is an antagonist for many cellular growth, proliferation and survival processes. When mutated or deleted, it causes cancers of the prostate, breast, colon, and brain. Researchers led by scientists at Memorial

New MSK research identified a way to reduce toxicity in CAR T cell therapy; discovered a division of labor in DNA repair that suggests a possible therapeutic strategy for certain cancers; developed a new method to enable imaging of two PET tracers simultaneously; found biomarkers that could help predict outcomes in HER2-positive metastatic esophagogastric cancer; and made progress toward improving options for patients with early-stage, potentially indolent cancers.

… Monday, July 17, 2023 New research from  Memorial Sloan Kettering Cancer Center (MSK)  and the  Sloan Kettering Institute  — a hub for basic science and translational research within MSK — discovered a division of labor in DNA repair that suggests a possible therapeutic strategy for certain cancers;

Memorial Sloan Kettering hosted its 24th annual “Thrivers” celebration to honor the patients, staff, and caregivers of the MSK Bone Marrow Transplantation (BMT) Service.

… Friday, September 13, 2019 It was a night of long hugs, standing ovations, well-earned tears, and “can you believe it?” stories, as Memorial Sloan Kettering hosted a lavish party to honor the patients, staff, and caregivers of MSK’s renowned Bone Marrow Transplant (BMT) Service . The event marked MSK

Take a look back at some of the year’s biggest news in cancer research.

… Thursday, December 27, 2018 December wouldn’t be complete without a recap of the year’s most important scientific advances in cancer. Memorial Sloan Kettering scientists published hundreds of studies this past year and weighed in as experts on many others. Below are some of the year’s highlights.   1

Collaborative team advances a new approach for imaging a drug that’s been developed to stop cancer growth.

… Friday, October 25, 2019 Summary Doctors and scientists from Memorial Sloan Kettering report on an innovative technique for noninvasively watching where a targeted therapy is going in the body. It also allows them to see how much of the drug reaches the tumor. Targeted therapy has become an important

Breast cancer risk varies widely among women who are carriers of the BRCA1 and BRCA2 mutations, according to a new study published in the January 9, 2008, issue of the Journal of the American Medical Association (JAMA).

… Tuesday, January 8, 2008 Breast cancer risk varies widely among women who are carriers of the BRCA1 and BRCA2 mutations, according to a new study published in the January 9, 2008, issue of the Journal of the American Medical Association ( JAMA ). “Our results underscore the conclusion that there is no

New MSK research examines how diabetes may speed the growth of multiple myeloma; analyzes the increasing number of patients who are benefiting from precision oncology; and highlights the unexpected role of the integrated stress response in response to genomic instability in mitochondrial DNA.

… Thursday, October 19, 2023 New research from Memorial Sloan Kettering Cancer Center (MSK) examines how diabetes may speed the growth of multiple myeloma; analyzes the increasing number of patients who are benefiting from precision oncology; and highlights the unexpected role of the integrated stress

… Monday, February 28, 2022 Charles Washington, Senior Director of Hospital Administration in Radiation Oncology, was born and raised in Detroit, Michigan. In 1967, when he was in third grade, he watched his neighborhood erupt in violence and looting during the Detroit Riots. Even as a young child, he

Memorial Sloan Kettering Cancer Center and Gerstner Sloan Kettering President Craig Thompson and his wife opened their home for a reception for prospective Gerstner Sloan Kettering students invited for admissions interviews.

… Tuesday, February 1, 2011 A cocktail reception at the home of Memorial Sloan Kettering Cancer Center and Gerstner Sloan Kettering President Craig Thompson and his wife, Tullia Lindsten, gave 42 prospective Gerstner Sloan Kettering students an opportunity to meet current Gerstner Sloan Kettering students